Ikuo Hatanaka

Effects of a new aldose reductase inhibitor on various tissues in vitro.

Hiroshi Terashima, K. Hama, Reiko Yamamoto et al. · Journal of Pharmacology and Experimental Therapeutics · 1984 · 137 citations

Effect of Prostaglandin E1 Analogue TFC 612 on Diabetic Neuropathy in Streptozocin-Induced Diabetic Rats Comparison With Aldose Reductase Inhibitor ONO 2235

Hitoshi Yasuda, Masanobu Sonobe, Makio Yamashita et al. · Diabetes · 1989 · 121 citations

Metabolic Syndrome, Medicine, Diabetes +11

Effect of a new aldose reductase inhibitor, (E)-3-carboxymethyl-5-[(2E)-methyl-3-phenylpropenylidene]rhodanine (ONO-2235) on peripheral nerve disorders in streptozotocin-diabetic rats

Ryuichi Kikkawa, Ikuo Hatanaka, H. Yasuda et al. · Diabetologia · 1983 · 112 citations · Full text

Biochemistry, Medicine, Diabetes +9

Decreased bone mineral density at the distal radius, but not at the lumbar spine or the femoral neck, in Japanese type 2 diabetic patients

T. Majima, Yasato Komatsu, Tomomi Yamada et al. · Osteoporosis International · 2004 · 98 citations

Bone Health, Body Composition, Medicine +7

Increased plasma plant sterol levels in heterozygotes with sitosterolemia and xanthomatosis.

Hideki Hidaka, Takaaki Nakamura, Toshikazu Aoki et al. · Journal of Lipid Research · 1990 · 80 citations · Full text

Nutrition, Botany, Genetics +20